FDA Investigator Edward O'shaughnessy
Edward O'shaughnessy has conducted inspections on 339 sites in 17 countries as of 23 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
339
Last Inspection Date:
23 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Jamaica,
Trinidad and Tobago,
Turkey,
Peru,
Malaysia,
Bulgaria,
China,
Mexico,
Spain,
India,
Belgium,
Vietnam,
Canada,
United Kingdom of Great Britain and Northern Ireland,
Japan,
Germany
FDA Investigators that have inspected at least one site in common with Edward O'shaughnessy:
Albert M Brindle,
Althea A Williams,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Anastasia I Offordile,
Andrew F Cohen,
Annemarie Bodnar,
Annemarie Kleiza,
Anthony M Criscuolo, Jr,
Antoinette L Ravelli,
Arduino Frankovic,
Arlyss M Jones,
Atul J Agrawal,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Brian D Young,
Brian R Yaun,
Brian Ravitch,
Byungja E Marciante,
Carol A Perry,
Carol A Robles,
Cary Greene,
Charisse K Green,
Charles J Chacko,
Charles M Edwards,
Charlotte P Chang,
Cherie T Parker,
Christina N Maurino,
Craig W Swanson,
David A Schwartz,
David G Whitman,
David H Smith,
David J Leray,
Dawn L Wydner,
Dena M Elimam,
Denise M Visco, Investigator,
Dennis L Doupnik,
Derek S Dealy,
Dessa A Antoine,
Devon Jenkins,
Dhaval H Patel,
Diana K Krepel,
Dolores Harper,
Doreen P Gubbay,
Dorothy J Denes,
Edith M Gonzalez,
Elizabeth D Connell,
Elizabeth P Mayer,
Emest F Bizjak,
Emmanuel Jramos Maldonado,
Eric Rothschild,
Esteban Beltran,
Felix Maldonado,
Frank J Marciniak,
Frederick F Razzaghi,
Gale L Glinecki,
Gianine E Delade,
Gianine E Tompkins,
Gillian B Nardelli,
Gobiga Vanniyasingam,
Grant L Davis,
Hitesh R Patel,
Huy T Pham,
Iqra Iftikhar,
Jacqueline A O'shaughnessy, PhD,
James R Birkenstamm,
Janaye A Young,
Jane C Chen,
Jason M Sluzynski,
Jason P Aun,
Jean M Kelahan,
Jennifer A Bazergui,
Jennifer A Robinson,
Jennifer L Custodio,
Jennifer Macmillan,
Jennifer R Mathern,
Jessica M Monteiro,
Jill Mielziner,
Jo Annc Declement,
Jonathan T Little,
Jonee J Mearns,
Jose M Cayuela,
Jose R Hernandez,
Joseph Duca,
Juan D Lopez,
Judith A Jones,
Judith A Paterson,
Justine Tomasso,
K Gonzlez,
Karen F Tomaziefski,
Karen M Labounty,
Karla J Gibler,
Kathleen J Close,
Keith A Schwartz,
Kelli A Giannattasio,
Kelli F Dobilas,
Kelly Doremus,
Kelly I Anderson,
Kenneth Nieves,
Kerry A Kurdilla,
Kinh Q Mac,
Kris K Moore,
Kristen E Rescigno,
Kristy A Zielny,
Kunapuli T Madhusudhan,
Kyle D Covill,
Laishan L Lam,
Larry K Austin,
Lata C Mathew, PhD,
Lauren E Sexton,
Lauren L Vajo,
Lawrence R Johnson,
Li Li,
Lisa B Hall,
Lisa Mathew,
Lorna F Jones,
LT Luis O Rodriguez,
LTJG Matthew R Palo,
Marcellinus D Dordunoo,
Marcelo O Mangalindan, Jr,
Maria Estrella,
Marjorie D Schultz,
Matthew A Johnson,
Megan E Kerry,
Megan E Kulas,
Melissa A Freeman,
Melissa A Zuppe,
Melissa B Libby,
Melissa T Roy,
Melka F Argaw,
Meredith L Sheridan,
Michael E Campbell,
Michael Rosner,
Michael Serrano,
Michelle M Parisi,
Mohammed H Adam,
Monica L Gutierrez,
Msdap Gonzlezk,
Nancy F Scheraga,
Neal D Singletary, PhD,
Nerizza B Guerin,
Nianna C Burns,
Nicholas A Violand,
Pedro A Cruz,
Peter M Trunk,
Phal K Chhun,
Ramanda C Gregory,
Raymond L Cheung,
Regina T Brown,
Remache,
Rene M Amaguana,
Richard D Manney,
Robert G Ruff,
Robert W Calais,
Rodrigo Vilchez,
Rupa Pradhan,
Saleem A Akhtar,
Sandra Kershaw,
Sarah Forney,
Schultz,
Sean D Duke,
Sean G Casey,
Seng Ching Hwang,
Sherri J Liu,
Sinai I Davis,
Sonia D Hudson,
Stephanie T Durso,
Steven S Wahl,
Susan M Halsted,
Tegan M Vanartsdalen,
Teigan M Mule,
Thomas J Hudson,
Thomas N Adjabeng,
Tracy M Portelli,
Tressa T Lewis,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
William W Dotts,
Young M Yoon,
Zakaria I Ganiyu
Edward O'shaughnessy's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2003 | EIR | Arctic Products Company Inc. - EIR, 2003-12-11 |
| March, 2002 | EIR | Ethicon, Inc. - EIR, 2002-03-25 |
| May, 2014 | FDA 483 | Flawless Beauty LLC - Form 483, 2014-05-16 |
| September, 2011 | FDA 483 | Beaver-Visitec International, Inc. - Form 483, 2011-09-16 |
| April, 2003 | FDA 483 | Zebu Enterprises, LLC - Form 483, 2003-04-30 |
| September, 2010 | FDA 483 | Vita Pure, Inc. - Form 483, 2010-09-23 |
| March, 2002 | FDA 483 Response | Ethicon, Inc. - Form 483R, 2002-03-25 |
| April, 2003 | EIR | Zebu Enterprises, LLC - EIR, 2003-04-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more